NCT00882024View on ClinicalTrials.gov

Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)

PHASE2CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Active Rheumatoid Arthritis
Interventions
DRUG

Tranilast

150 mg tranilast tablets, bid, 12 weeks

DRUG

Tranilast

75 mg tablets, bid, 12 weeks

DRUG

Placebo

Placebo tablets, bid, 12 weeks

Trial Locations (32)

Unknown

Mesa

Paradise Valley

La Jolla

San Diego

Aventura

Frederick

Lansing

Hickory

Duncansville

Capital Federal

Luján

Quilmes

Rosario

Plovdiv

Sofia

Brno-Bohunice

Ostrava-Hlucin

Prague

Zlín

Hamburg

Ludwigsfelde

Naumburg

Osnabrück

Ratingen

Wiesbaden

Mexicali

Guadalajara

Morelia

Obregón

Belgrade

Niška Banja

London

Sponsors
All Listed Sponsors
lead

Nuon Therapeutics, Inc.

INDUSTRY